A qualified South African veterinarian, with a PhD in vaccinologist(University of Pretoria), currently Head of Strategy and Business Development for MCI Santé Animale, largest African biopharmaceutical company, in Morocco.
I am one of 6 members of the Scientific Commission of the World Animal Health Organisation (OIE), Paris, France; and I am a Board member of the IVVN.
More than 20 years of international experience in vaccine research, development, manufacturing and commercialisation.
Form 1992 to 2001 I worked at ARC-Onderstepoort Veterinary Institute (South Africa) in different capacity, first as a researcher, then as head of the FMD vaccine development and production division. Between 2002 & 2008 I have been an executive at Onderstepoort Biological Products (OBP, South Africa), as CSO and COO.
From 2008 and 2014, in my capacity as Senior Director R&D for GALVmed, based in Edinburgh, UK, I was in charge of program development and scientific strategic direction of the organisation. I was overseeing product development activities and building international partnerships, which included the management of a pipeline portfolio of 24 products (vaccine, drugs and diagnostic tests), through partnerships with more than 50 institutions around the world, including research, academic, pharmaceutical and international organisations. Since 2014, I head the Strategy and Business development of MCI Sante animale.
Over the past 15 years, I have conducted consultancies in more than 20 African countries for different international organizations such as IAEA, FAO, as well as the African Union-IBAR and SADC.
I have one patent, more than 30 peer-reviewed articles to my credit, and more than 80 congress contributions and other publications.
Vaccine late development and delivery, virology, tropical infectious diseases